Figure 4.
Alemtuzumab in combination with Etoposide and Dexamethasone for the treatment of adult patients with Hemophagocytic Lymphohistiocytosis
Alemtuzumab in combination with Etoposide and Dexamethasone for the treatment of adult patients with Hemophagocytic Lymphohistiocytosis